An Integrated Approach to Visual Health and Medication Safety: Combining Optometric Assessment, Ocular Disease Screening, Pharmacological Management, and the Prevention of Drug-Related Visual Complications
DOI:
https://doi.org/10.70082/0hsrtb60Keywords:
optometry; vision screening; ocular toxicity; medication safety; drug monitoring; interprofessional careAbstract
Background: Reduced vision may reflect refractive error, ocular disease, or a medication effect. Screening and prescribing often take place in different services, creating opportunities for missed referrals or overdue monitoring. Objective: To synthesize evidence on how eye care and pharmacy teams can integrate ocular disease screening, pharmacological management, and prevention of medication-related visual complications in adult care. Methods: Targeted literature searches identified guidelines, systematic reviews, trials, and observational studies published through December 2024. Selected drug safety warnings were checked against dated regulatory documents. Results: Diabetes warrants scheduled retinal assessment even when vision is normal. Glaucoma evaluation requires interpretation of pressure, optic nerve findings, and visual fields in context. Safe ophthalmic prescribing depends on the indication, systemic contraindications, and the patient’s ability to use drops. Hydroxychloroquine, ethambutol, topiramate, corticosteroids, and pentosan polysulfate illustrate distinct patterns of harm that require different surveillance and responses. Conclusion: Integration is most useful when teams share a medication history, specify which test is needed and when, and verify that referrals and abnormal results lead to action. Acute symptoms require timely assessment, while equivocal surveillance findings should be confirmed before altering otherwise beneficial treatment.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
